Anindita Nayak
Bhubaneswar, 14 October 2025
Biotechnology is quickly reshaping sustainability, food systems and the way industries operate. By 2026, with breakthroughs in precision fermentation, bio-conversion and enzymatic recycling often supported by AI and automation, we are seeing the rise of sustainable food options, new ways to turn waste into valuable products, and the large-scale production of eco-friendly materials. These developments go beyond improving nutritional efficiency and resource use; they are also setting higher standards for waste reduction and responsible manufacturing. Altogether, this signals a significant step forward in building a healthier and more sustainable planet. Here are five biotech innovators to watch in 2026 advancing sustainability, food and industrial bioscience.
Arthro Biotech
Arthro Biotech was incorporated in 2023 in Hyderabad, India, by Dr. Praveen K. Sappa (CEO), Dr. Kishore Nalam, and Manikanth Injarapu and is an Indian startup that is a sustainable ingredient manufacturing leader. Utilizing black soldier fly (BSF) farming and biochemical conversion technology, the company recycles waste into value-added insect-derived products like protein meal for animal feed, biofertilizers, and functional extract for biopesticides and nutraceuticals. Having a closed-loop manufacturing process that integrates precision farming and waste valorization with traceability, resource efficiency and minimal environmental impact, even though currently not funded, Arthro Biotech was the first BSF manufacturing facility in India to achieve EU TRACES certification, thereby facilitating exports to Europe, Japan, and other countries. Having a potential production capability of 500 tons per annum with scalability up to 100,000 tons by 2030, the company is set to have a great influence on the world sustainable feed and agriculture markets.
Prevo Biotech
Prevo Biotech, established in 2023 in Freising, Germany, represents a notable development within the food technology sector. Under the leadership of Managing Director Jona Rott and a team dedicated to enhancing the resilience of food supply chains, the company leverages precision fermentation to generate natural compounds that address key challenges in plant-based food production. Their principal innovation, Dagon, is a protein-derived ingredient designed to interact synergistically with legume proteins. This approach mitigates undesirable flavor notes, enhances mouthfeel, and improves product stability. Such advancements enable producers of dairy alternatives, meat substitutes, and functional nutrition products to reduce sugar and salt content without resorting to artificial additives. Currently in its early growth phase, Prevo Biotech has secured approximately $10,600 in seed funding and receives support from organizations such as StartLife and EIT Food. Through the utilization of microalgae-based ingredients, the company aims to replace resource-intensive protein sources, underscoring its commitment to advancing sustainable practices within Germany and the broader European food industry.
Urobo Biotech
Urobo Biotech, established in 2023 in Stellenbosch, South Africa, represents a significant advancement in bioplastic waste management. Co-founded by Wessel Myburgh and Dominique Rocher, the company focuses on developing enzymatic recycling technologies that transform polylactic acid (PLA) bioplastics into valuable fuels and chemicals. Their approach integrates microbial and enzymatic solutions directly into established organic waste and plastic recycling systems, thereby eliminating the necessity for separate sorting. This integration enhances biogas production, reduces landfill dependence, and improves processing efficiency, while simultaneously generating new revenue opportunities for waste management facilities. Originating as a spin-out from Stellenbosch University in partnership with the University of Padua in Italy, Urobo Biotech has demonstrated early success. The company reached the finals of the Hult Prize, secured initial funding, and obtained a $23 million term sheet intended for large-scale waste-to-value infrastructure. With paid pilot projects currently operating in both South Africa and Italy, Urobo Biotech positions itself as a leading innovator within the emerging circular and sustainable bioeconomy.
Mara Bio
Mara Bio, established in 2023 in Tomoana, New Zealand, is a food-tech company focused on advancing sustainable production methods for food ingredients, aiming to bolster resilience within the global food system. The enterprise was co-founded by Mark Balchin, Steve Boggs, and Dr. Mehrnoush (Maya) Tangestani. The company utilizes a proprietary fungal fermentation platform to upcycle by-products from the food industry. Specifically, their edible fungi strain is cultivated through submerged fermentation and metabolizes residual sugars from waste streams such as dairy acid whey and spent grains to generate Flexitein which is a high-protein, high-fibre biomass, noted for its neutral taste and richness in essential amino acids. This ingredient is clean-label and allergen-free, making it suitable for use in beverages, snacks, and specialized nutrition applications. Mara Bio’s process is designed to minimize freshwater consumption and achieves superior carbon-to-protein efficiency compared to existing mycoprotein technologies. The company has secured $50,000 in seed funding, followed by a $1 million strategic round led by Climate Venture Capital Fund and K1W1. Rooted in Hawke’s Bay, Mara Bio aspires to make a substantial global impact by offering a climate-positive protein alternative to support sustainable food manufacturing.
Upli
Upli, a UK-based biotech startup established in 2024 by Dr. Bernd Alfons Gerhartz (serving as CSO) and Nina Kumari (CEO), is advancing innovations in the domains of functional food and medical nutrition. With its headquarters in Covent Garden, Upli concentrates on producing sustainable, bioidentical human milk proteins, specifically, alpha-lactalbumin using precision fermentation. This approach facilitates the enhancement of both infant and adult nutrition while eliminating reliance on animal-derived sources. By replicating the nutritional and functional attributes of breast milk, Upli’s products are intended to support immune, gastrointestinal, metabolic, and cognitive health. Focusing primarily on the European market, Upli’s technology offers a more ethical and potentially healthier alternative for the development of infant formula. The company has secured Seed funding from Plug and Play Tech Center. According to publicly available filings, Upli reports a turnover of less than £1 million and total assets below £500,000, which is indicative of its early-stage development and growth potential within the rapidly expanding bio-ingredient sector.
